Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Advancing immunity research with immune-integrated organ-on-a-chip technologies
Date
2026-10-01
Author
Ozefe, Fatih
Körükcü, Karya İpek
Tekin, Hilal
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
29
views
0
downloads
Cite This
Organ-on-a-chip (OoC) platforms are a key subclass of microphysiological systems (MPS), designed to mimic the dynamic and physiological properties of native human tissue and organs. These systems have attracted significant attention, particularly following the Food and Drug Administration (FDA) approval of their use in the pharmaceutical and biomedical industries as alternatives to traditional models. However, their physiological relevance is often limited due to the lack of functional immune compartments, which are responsible for maintaining homeostasis and to modulate disease progression in the human body. In this review, we present a critical overview of immune-integrated OoC platforms, highlighting their capacity to emulate complex immunological processes such as immune cell trafficking, extravasation, and cytokine-mediated inflammation. We further explore recent advances in microfluidic design and on-chip biosensor integrations to perform real-time monitoring of immune dynamics. Despite their immense potential for drug development and personalized medicine, we highlight that their clinical translation remains challenged by biological and microarchitectural limitations, the lack of systemic multi-organ networks, hurdles in on-chip biosensor integration, and operational drawbacks. Overall, we outline a strategic roadmap for the standardization of immunocompetent OoC platforms to generate the robust and reproducible datasets required for artificial intelligence (AI) models and subsequent FDA qualification.
Subject Keywords
Disease-on-a-chip
,
Immune organ
,
Microfluidics
,
Microphysiological systems
,
Organ-on-a-chip
,
Sensors
URI
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105046954581&origin=inward
https://hdl.handle.net/11511/120207
Journal
Biosensors and Bioelectronics: X
DOI
https://doi.org/10.1016/j.biosx.2026.100830
Collections
Department of Basic English, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
F. Ozefe, K. İ. Körükcü, and H. Tekin, “Advancing immunity research with immune-integrated organ-on-a-chip technologies,”
Biosensors and Bioelectronics: X
, vol. 32, pp. 0–0, 2026, Accessed: 00, 2026. [Online]. Available: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105046954581&origin=inward.